Hardly any more healing gonorrhea therapy gonorrhea becomes a death trap
The venereal disease gonorrhea seems to be increasingly difficult to combat. As the World Health Organization (WHO) reports, are the causative agents of the - commonly known as "gonorrhea" - infectious disease, more resistant to all antibiotics insensitive. A big problem, because the disease remains untreated, threaten chronic inflammation of the genital organs and even infertility. Worldwide According to the WHO, each one is estimated to be infected by gonorrhea by an estimated 78 million people worldwide.
Tripper is caused by gonococci
Gonorrhea is one of the most common sexually transmitted diseases. The disease, also known as gonorrhea, is caused by the bacterium "Neisseria gonorrhoeae" (gonococci) and can therefore only be specifically controlled with antibiotics. But that seems to be getting more and more difficult because, as the World Health Organization (WHO) informs, most drugs have now developed resistance and lost their effectiveness.
Choice of drugs is getting smaller
Currently, there are hardly any drugs available that could help with gonorrhea, according to the latest release. Thus, at present only three new chemical substances would be in different stages of clinical trials.
"The bacteria that cause gonorrhea are especially smart. Every time we use a new class of antibiotics to treat the infection, the bacteria evolve to withstand them, "said Dr. Teodora Wi from WHO according to the message.
Disease can lead to infertility
A problematic situation, because the disease is not treated, threatening late effects such. Inflammation of the ovaries in the woman or the epididymis in men and permanent infertility. In addition, an infection increases the risk of HIV. In rare cases, the pathogens can enter the body via the blood, causing joint inflammation or even heart valve inflammation (systemic infection)..
Nearly 80 million new cases annually
Every year, an estimated 78 million people become infected with gonorrhea, with infection almost always occurring through unprotected sexual intercourse. According to the WHO, Africa is the continent with the highest number of infections. The health organization had already warned in a report from last year that "the antibiotic resistance of sexually transmitted diseases has increased rapidly, gonorrhea, syphilis and chlamydiosis, which has shrunk the possibilities of treatment."
Improved laboratory diagnostics necessary
Accordingly, certain gonorrhea strains would no longer respond to any of the available antibiotics, according to the WHO. Although the resistance to chlamydia and syphilis is less common, it would still make prevention and immediate treatment more difficult. These diseases affect 131 million or 5.6 million people each year.
"To control gonorrhea, we need new equipment and systems [...]. Specifically, we need new antibiotics, as well as fast, accurate, near-patient laboratory diagnostics - ideally one that can predict which antibiotic agents will target a specific infection - and longer term a gonorrhea prevention vaccine. " Marc Sprenger, Director of Antimicrobial Resistance at WHO. (No)